Gerald A. Denys

1.1k total citations
46 papers, 850 citations indexed

About

Gerald A. Denys is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Gerald A. Denys has authored 46 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 19 papers in Epidemiology and 15 papers in Clinical Biochemistry. Recurrent topics in Gerald A. Denys's work include Bacterial Identification and Susceptibility Testing (15 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Antibiotic Resistance in Bacteria (13 papers). Gerald A. Denys is often cited by papers focused on Bacterial Identification and Susceptibility Testing (15 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Antibiotic Resistance in Bacteria (13 papers). Gerald A. Denys collaborates with scholars based in United States, Canada and Ukraine. Gerald A. Denys's co-authors include Michael Kays, Matthew F. Wack, David W. Smith, Michael J. Dowzicky, Miguel A. Arroyo, Karen Bush, Chris A. Brown, Roberta B. Carey, Ronald N. Jones and Steven M. Callister and has published in prestigious journals such as Analytical Chemistry, Spine and Journal of Clinical Microbiology.

In The Last Decade

Gerald A. Denys

45 papers receiving 798 citations

Peers

Countries citing papers authored by Gerald A. Denys

Since Specialization

Citations

This map shows the geographic impact of Gerald A. Denys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald A. Denys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald A. Denys more than expected).

Fields of papers citing papers by Gerald A. Denys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald A. Denys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald A. Denys. The network helps show where Gerald A. Denys may publish in the future.

Co-authorship network of co-authors of Gerald A. Denys

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald A. Denys. A scholar is included among the top collaborators of Gerald A. Denys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald A. Denys. Gerald A. Denys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of the Bio-Response Solutions Human-28 Low-Temperature Alkaline Hydrolysis System 2019 ·Applied Biosafety ·Gerald A. Denys	2
2	Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa 2018 ·Journal of Clinical Microbiology ·Adam L. Bailey, (unknown), (unknown), Gerald A. Denys, Janet A. Hindler, Shelley Campeau, Maria M. Traczewski, Romney M. Humphries, Carey‐Ann D. Burnham	9
3	Multicenter Evaluation of the Portrait Staph ID/R Blood Culture Panel for Rapid Identification of Staphylococci and Detection of the mecA Gene 2017 ·Journal of Clinical Microbiology ·Gerald A. Denys, (unknown), Stephen Young, Judy A. Daly, Marc Roger Couturier, Matthew L. Faron, Blake W. Buchan, Nathan A. Ledeboer	2
4	Propionibacterium acnes, Coagulase-Negative Staphylococcus, and the “Biofilm-like” Intervertebral Disc 2016 ·Spine ·Michael F. Coscia, Gerald A. Denys, Matthew F. Wack	44
5	Antibiotic Resistance in Nosocomial Respiratory Infections 2014 ·Clinics in Laboratory Medicine ·Gerald A. Denys, Ryan F. Relich	19
6	Portrait ToxigenicClostridium difficileassay, an isothermal amplification assay detects toxigenicC. difficilein clinical stool specimens 2013 ·Expert Review of Molecular Diagnostics ·Gerald A. Denys	6
7	In vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against Gram-positive and Gram-negative pathogens 2010 ·Journal of Antimicrobial Chemotherapy ·Gerald A. Denys, (unknown), P O’Hanley, (unknown)	10
8	Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology 2007 ·International Journal of Antimicrobial Agents ·Michael Kays, (unknown), Gerald A. Denys	6
9	Selection of a gyrA Mutation and Treatment Failure with Gatifloxacin in a Patient with Streptococcus pneumoniae with a Preexisting parC Mutation 2007 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Michael Kays, George G. Zhanel, (unknown), Judith Jacobi, Gerald A. Denys, David W. Smith, Matthew F. Wack	6
10	Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial 2007 ·American Journal of Infection Control ·Gerald A. Denys, (unknown), Michael J. Dowzicky	15
11	Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003–2004) 2006 ·Journal of Antimicrobial Chemotherapy ·Amy A. Watters, Ronald N. Jones, Jennifer A. Leeds, Gerald A. Denys, Hélio S. Sader, Thomas R. Fritsche	25
12	Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation 2002 ·Diagnostic Microbiology and Infectious Disease ·Michael Kays, Matthew F. Wack, David W. Smith, Gerald A. Denys	29
13	Levofloxacin Treatment Failure in a Patient with Fluoroquinolone‐Resistant Streptococcus pneumoniae Pneumonia 2002 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Michael Kays, David W. Smith, Matthew F. Wack, Gerald A. Denys	80
14	Evaluation of BACTEC MYCO/F Lytic Medium for Recovery of Mycobacteria, Fungi, and Bacteria from Blood 2001 ·Journal of Clinical Microbiology ·DeAnna D. Fuller, Thomas E. Davis, Gerald A. Denys, Mary K. York	41
15	Fluoroquinolone susceptibility, resistance, and pharmacodynamics versus clinical isolates of Streptococcus pneumoniae from Indiana 2001 ·Diagnostic Microbiology and Infectious Disease ·Michael Kays, Gerald A. Denys	13
16	Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): Case reports from the SENTRY antimicrobial surveillance program 2000 ·Diagnostic Microbiology and Infectious Disease ·Kari C. Kugler, Gerald A. Denys, Michael L. Wilson, Ronald N. Jones	7
17	APIC position paper: Responsibility for interpretation of the PPD tuberculin skin test 1999 ·American Journal of Infection Control ·(unknown), Gerald A. Denys, Loretta Fauerbach, (unknown), (unknown), (unknown), David Rimland, (unknown), (unknown)	6
18	APIC position paper: Hepatitis C exposure in the health care setting 1999 ·American Journal of Infection Control ·(unknown), Gerald A. Denys, Loretta Fauerbach, (unknown), (unknown), (unknown), David Rimland, (unknown), (unknown)	3
19	APIC position paper: Immunization 1999 ·American Journal of Infection Control ·(unknown), Gerald A. Denys, Loretta Fauerbach, (unknown), (unknown), (unknown), David Rimland, (unknown), Janice M. Zeller	7
20	Sterilization, decontamination, and disinfection procedures for the microbiology laboratory 1995 ·(unknown), Gerald A. Denys	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact